Biomarin Pharmaceutical shares owned by Morgan Stanley
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $3.4M | 3.6M | 0.94 |
| 2024-12-31 | $9.0M | 9.7M | 0.93 |
| 2024-09-30 | $9.2M | 9.7M | 0.95 |
| 2024-06-30 | $9.9M | 10M | 0.95 |
| 2024-03-31 | $10M | 10M | 0.99 |
| 2023-12-31 | $9.8M | 9.5M | 1.03 |
| 2023-09-30 | $8.7M | 8.8M | 0.99 |
| 2023-06-30 | $6.4M | 6.4M | 1.00 |
| 2022-12-31 | $2.8M | 2.6M | 1.07 |
| 2022-06-30 | $66k | 66k | 1.00 |
| 2022-03-31 | $531k | 530k | 1.00 |
| 2021-06-30 | $232k | 231k | 1.00 |